Despite yet unknown mechanisms and moderate hH3R affinity, compound 16 (QD13) constitutes a novel, potential dual acting H3R ligand-promising starting point towards treatment of neurologic disorders associated with increased neuronal oxidative stress. The gene discussed is HRH3; the disease is nervous system disorder.